Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Oaktree Acquisition Corp. III Life Sciences (OACC)

Oaktree Acquisition Corp. III Life Sciences: 13,326,977 shares tendered for redemption

Neutral Impact 3 of 5 shareholder Written later

Oaktree Acquisition Corp. III Life Sciences disclosed preliminary results of its shareholder redemption window ahead of an extension meeting. Holders tendered 13,326,977 Class A ordinary shares for redemption before the October 14, 2026 deadline. After the redemptions and a planned conversion of sponsor-held Class B shares, the company expects 11,254,791 Class A and 1,000 Class B ordinary shares to remain outstanding, which matters to shareholders because it sets the share count ahead of the proposed deadline extension.

Key points

  • Redemption deadline was 5:00 p.m. Eastern Time on October 14, 2026.
  • 13,326,977 Class A ordinary shares were tendered for redemption before the deadline.
  • Sponsor intends to convert 4,798,758 Class B ordinary shares into Class A ordinary shares before the extension takes effect.
  • Shareholders meeting to vote on the extension is scheduled for October 16, 2026.

The filing

CompanyOaktree Acquisition Corp. III Life Sciences (OACC)
Form8-K, current report
Filed with the SECOct 15, 2026, 7:09 AM ET
Accession number0001193125-26-422263

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.